166 related articles for article (PubMed ID: 9715793)
1. Effects of losartan and captopril on endothelin-1 production in blood vessels and glomeruli of rats with reduced renal mass.
Larivière R; Lebel M; Kingma I; Grose JH; Boucher D
Am J Hypertens; 1998 Aug; 11(8 Pt 1):989-97. PubMed ID: 9715793
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats.
Dumont Y; D'Amours M; Lebel M; Larivière R
J Hypertens; 2001 Aug; 19(8):1479-87. PubMed ID: 11518857
[TBL] [Abstract][Full Text] [Related]
3. Increased immunoreactive endothelin-1 levels in blood vessels and glomeruli of rats with reduced renal mass.
Larivière R; D'Amours M; Lebel M; Kingma I; Grose JH; Caron L
Kidney Blood Press Res; 1997; 20(6):372-80. PubMed ID: 9453448
[TBL] [Abstract][Full Text] [Related]
4. Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II.
D'Amours M; Lebel M; Grose JH; Larivière R
Can J Physiol Pharmacol; 1999 Jan; 77(1):8-16. PubMed ID: 10535660
[TBL] [Abstract][Full Text] [Related]
5. Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats.
Brochu E; Lacasse S; Moreau C; Lebel M; Kingma I; Grose JH; Larivière R
Nephrol Dial Transplant; 1999 Aug; 14(8):1881-8. PubMed ID: 10462266
[TBL] [Abstract][Full Text] [Related]
6. Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats.
Dumont Y; D'Amours M; Lebel M; Larivière R
Nephrol Dial Transplant; 2001 Apr; 16(4):746-54. PubMed ID: 11274268
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
8. Renal angiotensin II receptor regulation in two-kidney, one clip hypertensive rats: effect of ACE inhibition.
Amiri F; Garcia R
Hypertension; 1997 Sep; 30(3 Pt 1):337-44. PubMed ID: 9314414
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
10. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension.
Racasan S; Hahnel B; van der Giezen DM; Blezer EL; Goldschmeding R; Braam B; Kriz W; Koomans HA; Joles JA
Kidney Int; 2004 Feb; 65(2):575-81. PubMed ID: 14717927
[TBL] [Abstract][Full Text] [Related]
11. Renal angiotensin II receptors and protein kinase C in diabetic rats: effects of insulin and ACE inhibition.
Amiri F; Garcia R
Am J Physiol Renal Physiol; 2000 Apr; 278(4):F603-12. PubMed ID: 10751221
[TBL] [Abstract][Full Text] [Related]
12. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats.
Lavoie P; Robitaille G; Agharazii M; Ledbetter S; Lebel M; Larivière R
J Hypertens; 2005 Oct; 23(10):1895-903. PubMed ID: 16148614
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.
Yousif MH; Dhaunsi GS; Makki BM; Qabazard BA; Akhtar S; Benter IF
Pharmacol Res; 2012 Sep; 66(3):269-75. PubMed ID: 22580236
[TBL] [Abstract][Full Text] [Related]
15. Despite similar reduction of blood pressure and renal ANG II and ET-1 levels aliskiren but not losartan normalizes albuminuria in hypertensive Ren-2 rats.
Vaňourková Z; Kramer HJ; Husková Z; Cervenka L; Vaněčková I
Physiol Res; 2010; 59(3):339-345. PubMed ID: 20666571
[TBL] [Abstract][Full Text] [Related]
16. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510
[TBL] [Abstract][Full Text] [Related]
17. Renal angiotensin II receptor regulation and renin-angiotensin system inhibition in one-kidney, one clip hypertensive rats.
Amiri F; Haddad G; Garcia R
J Hypertens; 1999 Feb; 17(2):279-86. PubMed ID: 10067798
[TBL] [Abstract][Full Text] [Related]
18. Effect of losartan on angiotensin II-mediated endothelin and prostanoid excretion in humans.
Quest DW; Gopalakrishnan V; McNeill JR; Wilson TW
Am J Hypertens; 2000 Dec; 13(12):1288-94. PubMed ID: 11130773
[TBL] [Abstract][Full Text] [Related]
19. Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition.
Qiu C; Baylis C
Kidney Int; 1999 Jun; 55(6):2390-6. PubMed ID: 10354287
[TBL] [Abstract][Full Text] [Related]
20. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations.
Verhagen AM; Braam B; Boer P; Gröne HJ; Koomans HA; Joles JA
Kidney Int; 1999 Jul; 56(1):222-31. PubMed ID: 10411696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
